Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FC4J8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,461
Award facts
- Contract value 100% obligated
- $13,460.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors in 2 ml formulations, with a ceiling value of $13,460.84. This is a firm fixed-price delivery order with an ultimate completion date of May 21, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 billion through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Cosentyx is a biologic immunosuppressant used to treat inflammatory conditions, and this delivery order fulfills specific medical supply requirements under the DLA's broader pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DB25FC4J8?
SPE2DB25FC4J8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 20, 2025.
How much is contract SPE2DB25FC4J8 worth?
The government has obligated $13,461 on SPE2DB25FC4J8.
Is contract SPE2DB25FC4J8 an order under another contract?
Yes. SPE2DB25FC4J8 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FC4J8 competed?
The extent of competition for SPE2DB25FC4J8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award